-
Yum's Guidance Increase Makes Up For Weak Q2 Sales, Says BTIG
Thursday, July 14, 2016 - 11:28am | 328Read More...Although Yum! Brands, Inc. (NYSE: YUM) reported weaker-than-expected 2Q16 results, especially on the top line, BTIG’s Peter Saleh believes there were sufficient positive elements to support the stock. Saleh maintains a Neutral rating on the company. “We expect investors will be...
-
Seagate Has To Prove Itself Over 6-9 Months Says BTIG; Reiterates Buy
Tuesday, July 12, 2016 - 8:12am | 294Read More...Seagate Technology PLC (NASDAQ: STX) has announced the preliminary results for 4Q16 above the high end of guidance, driven by increased HDD demand and significantly higher ASP. BTIG’s Edward Parker reiterated a Buy rating on the company, with a price target of $30. Results Preview Seagate...
-
Boingo Wireless Initiated At Sell By BTIG Research
Monday, July 11, 2016 - 10:10am | 324Read More...BTIG’s Walter Piecyk expects Boingo Wireless Inc (NASDAQ: WIFI) to deliver revenue and EBITDA growth, while returning to free cash flow, in 2017. However, the analyst believes the surge in the stock already reflects these factors. Piecyk initiated coverage of the company with a Sell rating...
-
Analysts Give Healthcare Sector A Clean Bill Of Health
Friday, June 17, 2016 - 9:33am | 255Read More...Here’s a summary of recent analyst coverage on Healthcare: Bernstein on HCA Holdings Inc (NYSE: HCA): Market Perform, $88 Price Target Bernstein on UnitedHealth Group Inc (NYSE: UNH): Outperform, $142 Price Target Morgan Stanley on Cepheid (NASDAQ: CPHD): Equal Weight, $30 Price Target...
-
BTIG Still Buying Relypsa As May Prescription Trends Show Steady Veltassa Increases
Thursday, June 16, 2016 - 11:04am | 283Read More...Relypsa Inc (NASDAQ: RLYP) reported that paid prescriptions for Veltassa in hyperkalemia increased to 1,230 in May, from 928 in April, and that 1,385 free starter packs were dispensed, representing a 14 percent increase from April. BTIG’s Timothy Chiang maintained a Buy rating on the...
-
Medtronic's Spine Division Continues To Lag The Market
Tuesday, June 7, 2016 - 11:05am | 273Read More...Medtronic PLC (NYSE: MDT) provided further details regarding its revenue and EPS growth plan, which BTIG’s Sean Lavin views as achievable. Lavin maintains a Neutral rating on the company. Medtronic’s Goals “While we hope MDT hits these goals; with continued pricing pressure and a...
-
BTIG Starts MacroGenics At Buy, Sees 63% Upside
Thursday, April 7, 2016 - 5:29pm | 196Read More...BTIG Research's Dane Leone initiated coverage on a cancer treatment and infectious disease biotech company Thursday afternoon, MacroGenics Inc (NASDAQ: MGNX). The analyst set a Buy rating and $35 price target, representing potential upside of about 63 percent from the stock's close....
-
Intuitive Surgical Shares Downgraded To Neutral At BTIG
Friday, April 1, 2016 - 11:06am | 188Read More...BTIG issued a note on Intuitive Surgical Inc. (NASDAQ: ISRG) after recent analysis showed limited share appreciation in the near term due to a high valuation. Analysts downgraded Intuitive Surgical to Neutral while a price target is currently unavailable. Analysts Sean Lavin and Karen Koski...
-
Hedge Fund Manager: Disney's CEO Needs To 'Talk Straight'
Monday, December 28, 2015 - 2:54pm | 252Read More...Eric Jackson is the managing director of SpringOwl and penned an article on The Street's Real Money on why Walt Disney Co (NYSE: DIS)'s CEO Bob Iger needs to "talk straight." Jackson noted that Iger was recently a guest on Bloomberg TV and discussed an unnamed analyst's (...
-
The Downgrade That Sent Disney Shares Lower
Friday, December 18, 2015 - 12:42pm | 411Read More...Shares of Walt Disney Co (NYSE: DIS) lost nearly 3 percent Friday morning. Rich Greenfield of BTIG downgraded Disney's stock to Sell. The analyst expressed caution over the latest "Star Wars" film and ongoing concerns surrounding ESPN. While "Star Wars" fanatics...
-
BTIG Research Initiates Teva Pharmaceutical At Buy
Tuesday, July 7, 2015 - 8:20am | 68Read More...Analysts at BTIG Research initiated coverage on Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) with a Buy rating. The target price for Teva Pharmaceutical is set to $77. Teva Pharmaceutical shares have gained 15.77 percent over the past 52 weeks, while the S&P 500 index has surged 5.35...
-
BTIG Research Downgrades Assured Guaranty To Neutral
Monday, June 29, 2015 - 9:25am | 53Read More...BTIG Research downgraded Assured Guaranty Ltd. (NYSE: AGO) from Buy to Neutral. Assured Guaranty shares have gained 11.92 percent over the past 52 weeks, while the S&P 500 index has surged 7.17 percent in the same period. Assured Guaranty shares fell 12.62 percent to $23.95 in after-hours...
-
BTIG Research Initiates Crown Castle International With Buy
Thursday, June 18, 2015 - 8:32am | 70Read More...Analysts at BTIG Research initiated coverage on Crown Castle International Corp (NYSE: CCI) with a Buy rating. The target price for Crown Castle International is set to $95 Crown Castle International shares have gained 11.64 percent over the past 52 weeks, while the S&P 500 index has surged 7....
-
BTIG Research Upgrades FactSet Research Systems To Neutral
Wednesday, June 17, 2015 - 8:18am | 58Read More...Analysts at BTIG Research upgraded FactSet Research Systems Inc. (NYSE: FDS) from Sell to Neutral. FactSet Research Systems shares have gained 41.46 percent over the past 52 weeks, while the S&P 500 index has surged 7.12 percent in the same period. FactSet Research Systems' shares jumped 0.20...
-
US Stock Futures Up; All Eyes On Fed Decision
Wednesday, June 17, 2015 - 7:29am | 484Read More...Pre-open movers US stock futures traded higher in early pre-market trade. The FOMC will announce its policy decision at 2:00 p.m. ET, while the Fed Chairwoman Janet Yellen will hold a press conference at 2:30 p.m. ET. Futures for the Dow Jones Industrial Average climbed 32.50 points to 17,858.50,...
